Detroit R&D Awarded $1M Phase II SBIR Grant | GenomeWeb

NEW YORK (GenomeWeb News) – Detroit R&D today announced it has been granted a two-year $1 million Small Business Innovation Research Phase II grant to continue research into protein glycosylation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.